The placenta and the womb nourish and protect developing babies. A research team led by Nicolas Rivron at IMBA (Institute of Molecular Biotechnology of the Austrian Academy of Sciences) has now discovered that, in the earliest stage of development, the embryo is in control and determines this environment itself. Whilst the so-called blastocyst is still floating in the womb, this early embryo can give instructions to the placenta and the womb so that it can implant itself.
For their research, Rivron and his team have developed ‘blastoids’, which are in vitro models of blastocysts. These correspond to mammalian embryos in the early days following fertilisation, but represent an ethical alternative to the use of embryos in research. The blastoids were created in 2018 from mouse stem cells, and last year also from human stem cells.
A blastocyst consists of around 200 different types of stem cells. The cells inside this cell mass later develop into the foetus (epiblast). The outer layer contains the trophoblasts, which later form the placenta. Rivron’s research team has now discovered that epiblasts secrete several molecular signalling molecules to the trophoblasts, instructing them to renew and multiply themselves and to alter the uterine tissue. “In this way, the embryo invests in its own future: it promotes the formation of the tissues that will subsequently ensure its development. The embryo is in control by steering the creation of an environment in which it can thrive,” explains Rivron.
The researchers also discovered that these molecular signalling molecules prompt the trophoblasts to secrete two further molecules, WNT6 and WNT7B. WNT6 and WNT7B, in turn, instruct the uterus to envelop the blastocyst. The team gained these insights, amongst other things, by studying mouse blastoids in an in vivo implantation model within the mouse uterus. “I was very surprised by the efficiency with which our blastoids implanted in the uterus. And by altering the properties of the trophoblasts within the blastoids, including the secretion of WNT6/7B, we were able to significantly alter the size of the amniotic cavity,” explains co-first author Jinwoo Seong, a postdoctoral researcher in Rivron’s laboratory who carried out these experiments.
In human pregnancies, implantation is a critical factor. Around one in two pregnancies fails at this stage. Rivron and his team are currently using human blastoids in the laboratory to investigate whether these fundamental developmental principles are also preserved in humans during the early stages of development. “These discoveries could contribute not only to improving IVF procedures and developing fertility drugs, but also to novel contraceptives,” Rivron suggests.
Reference:
Institute of Molecular Biotechnology of the Austrian Academy of Sciences
Seong J et al., Epiblast inducers capture mouse trophectoderm stem cells in vitro and pattern blastoids for implantation in utero, Cell Stem Cell, 29(7):P1102-1118.E8, 7 July 2022
DOI:https://doi.org/10.1016/j.stem.2022.06.002
#embryo #pregnancy #foetus #blastocyst #blastoid #imba #science